BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250627T133000
DTEND;TZID=Europe/Vienna:20250627T143000
DTSTAMP:20260420T010736
CREATED:20241017T080743Z
LAST-MODIFIED:20250624T092530Z
UID:1932-1751031000-1751034600@esmit.eanm.org
SUMMARY:Extravascular Administration in Diagnostic and Therapeutic Nuclear Medicine
DESCRIPTION:In nuclear medicine\, diagnostic as well as therapeutic\, radiopharmaceuticals are administered via an intravenous injection\, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally\, the injection fails\, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may be a locally high radiation dose at the injection site\, in some situations high enough to cause severe tissue effects on the patient. Thus\, it is important to recognize the problem and identify the cause in order to decrease the risk. Furthermore\, the management of the situation after such an extravasation must be dealt with thoroughly and this has been the subject of lively debate in recent years. The parameters that have an impact on the radiation dose are among other things\, the physical properties of the radionuclide\, as well as the activity and volume of the radioactive substance retained in the surroundings of the blood vessel. In the case when most of the administered activity ends up extravascular\, the quality of the diagnostic procedure or the effect of the treatment are negatively affected\, which must be addressed. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\nThe aim of this webinar is to highlight the risk and consequences of extravascular administration of radiopharmaceuticals as well as the management of the situation after an extravasation. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nPhysicists\, Physicians\, Technologists\, Nurses \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSiria MediciSpeaker \n\n\n\n\n\nJochem van der Pol Speaker \n\n\n\n\n\nSigrid Leide SvegbornModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/extravascular-administration-in-diagnostic-and-therapeutic-nuclear-medicine/
CATEGORIES:Instrumentation, Technology, Science,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250613T133000
DTEND;TZID=Europe/Vienna:20250613T143000
DTSTAMP:20260420T010736
CREATED:20241017T081027Z
LAST-MODIFIED:20250605T095541Z
UID:1934-1749821400-1749825000@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: Do We Need Quantification?
DESCRIPTION:This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context\, the relevance of quantification to characterize disease and how to assess reliably the effects of therapy are presented. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo gain a insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nTo learn the possibilities of quantification of planar and SPECT studies in amyloidosis\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics and quantification\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nFederico CaobelliSpeaker \n\n\n\n\n\nIan ArmstrongSpeaker \n\n\n\n\n\nCarmela NappiModerator \n\n\n\n\n\nStephan NekollaModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-do-we-need-quantification/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250605T090000
DTEND;TZID=Europe/Vienna:20250606T160000
DTSTAMP:20260420T010736
CREATED:20241017T084223Z
LAST-MODIFIED:20250522T130904Z
UID:1964-1749114000-1749225600@esmit.eanm.org
SUMMARY:GMP for Radiopharmaceuticals
DESCRIPTION:The GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality\, from batch to batch\, for clinical use.  \n\n\n\nThe Basics of cGMP is a 2 days on-site ESMIT course\, providing guidance through EU-cGMP regulation for manufacturing\, testing\, and quality assurance of radiopharmaceuticals in order to ensure that a manufactured product is safe for human use. Principles regarding facilities\, equipment qualification\, controlled environmental conditions\, processes and methods validation\, standard operation procedures and user specific requirement\, risk assessment\, and specifications will be detailed. Also\, the main components of investigational new drug and marketing authorisation dossiers will be discussed. \n\n\n\n\n\n\n\nRegister nowThe registration is closed. Please contact us at esmit@eanm.org if you still want to register. \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nGeneral knowledge regarding GMP and cGMP for Radiopharmaceuticals principles and guidelines. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nRadiopharmacists and radiochemists in translational research\, hospital radiopharmacy and radiopharmaceutical production centres. \n\n\n\n \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDana NiculaeSpeakerBucharest\, Romania \n\n\n\n\n\nPhilip ElsingaSpeakerGroningen\, Netherlands \n\n\n\n\n\nAntero AbrunhosaSpeakerCoimbra\, Portugal \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/gmp-for-radiopharmaceuticals/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course,Radiopharmaceuticals
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250601T000000
DTEND;TZID=Europe/Vienna:20250601T235959
DTSTAMP:20260420T010736
CREATED:20251030T142906Z
LAST-MODIFIED:20251031T095911Z
UID:1346-1748736000-1748822399@esmit.eanm.org
SUMMARY:Bringing Alpha Therapies into Clinical Practice
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\n \n\n\n\n \n\n\n\nThis online course offers a comprehensive introduction to alpha therapy in nuclear medicine\, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences\, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various\, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available\, describing all important steps required for production and radiopharmaceutical development. The advantages\, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials\, with the best yet to come. Dosimetry will play a pivotal role in this course\, underlying its role in clinical practice. Finally\, The Alphamet project will be presented\, allowing you to get updated with the latest insights from Theranostics. \n\n\n\nRPH \n\n\n\nTargeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment\, harnessing the potent\, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT\, highlighting its exceptional potency\, unique ability to overcome radio-resistance\, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides\, the biological advantages of short-range high-energy emissions\, and the complex challenges involved in the development\, production\, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology. \n\n\n\nOncology \n\n\n\n \n\n\n\nIn this part of the course\, participants will explore the main advantages of alpha-emitting radionuclides in oncology\, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy\, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials\, providing valuable knowledge on the future direction of this rapidly evolving field. \n\n\n\nDosimetry \n\n\n\nParticipants will begin by exploring the basic concepts of dosimetry with alpha emitters\, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry\, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition\, the course presents the Alphamet project\, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet\, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTo gain an overview of the main advantages of Alpha-radionuclides\n\n\n\nTo learn about the challenges of alpha emitters\, complex production; transport issues\, waste management and handling\n\n\n\nTo get insights on radiobiology: radiotoxicity & effectiveness\n\n\n\nTo have a comprehensive review of research candidates\n\n\n\nTo provide an overview of the main advantages when using Alpha-Therapy in clinical practice\n\n\n\nTo learn about the clinical challenges when using Alpha-Therapy\n\n\n\nTo get insights into current and future trials focusing on Alpha-Therapy\n\n\n\nTo learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters\n\n\n\nTo learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters\n\n\n\nTo learn on the Alphamet project\, which addresses the unique and unmet metrological challenges of targeted alpha therapies\, contributing to their safe and optimised implementation into routine clinical practice\n\n\n\n\n\n\n\nNuclear medicine physicians\, radiologists\, medical oncologists\, urologists\, radiation oncologists\, medical physicists\, biologists\, researchers\n\n\n\nRadiochemists\, radiopharmacists\, physicists\, medical physicists\, biologists\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nDana NiculaeSpeaker \n\n\n\nMarianna TosatoSpeaker \n\n\n\nPablo Mínguez GabiñaSpealer \n\n\n\nAna Denis-BacelarSpeaker \n\n\n\n\n\nEmma AnaheimSpeaker \n\n\n\nWolfgang FendlerSpeaker \n\n\n\nMike SathekgeSpeaker \n\n\n\nJoe O’SullivanSpeaker \n\n\n\n\n\nJanke KleynhansSpeaker \n\n\n\nMathias ZacherlSpeaker \n\n\n\nDaniela Oprea-LagerSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once registered\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bringing-alpha-therapies-into-clinical-practice/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Online Course,Radiopharmaceuticals,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250601T000000
DTEND;TZID=Europe/Vienna:20250601T235959
DTSTAMP:20260420T010736
CREATED:20240215T124600Z
LAST-MODIFIED:20251016T123616Z
UID:1358-1748736000-1748822399@esmit.eanm.org
SUMMARY:Parathyroid Imaging (Self-paced)
DESCRIPTION:UEMS EACCME has granted the accreditation of 2.5 CME credits for this event. \n\n\n\nThis self-paced online course will offer a comprehensive exploration of the anatomy\, physiology\, and diagnostic tools related to parathyroid glands disorders. The course will cover a range of topics\, including the regulation of parathyroid hormone (PTH) secretion and his mechanisms of action\, etiology\, clinical manifestations\, and notably the diagnostic approaches ( laboratory and imaging)\, and treatment modalities especially concerning hyperparathyroidism. \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nAttendees will gain insights into structure and function of the parathyroid glands\, earning about etiology\, clinical manifestations\, diagnostic approaches focused on nuclear medicine and radiological techniques and treatment modalities of hyperparathyroidism. Through lectures\, and case studies\, participants will acquire the knowledge and skills necessary to diagnose and manage parathyroid disorders. \n\n\n\n\n\n\n\nTarget audience\n\n\n\n \n\n\n\nThis course is designed for Nuclear Medicine Physicians\, Endocrinologists and Radiologists. \n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\nLuca GiovanellaZurich\, Switzerland \n\n\n\nMurat TuncelAnkara\, Türkiye \n\n\n\nMichael KreisslMagdeburg\, Germany \n\n\n\nPetra PetranovicZagreb\, Croatia \n\n\n\n\nRegistration Details\n\n\n\nRegistration Fee\n\nCourse Fee              Free \n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once enrolled\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/parathyroid-imaging/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250520T130000
DTEND;TZID=Europe/Vienna:20250521T170000
DTSTAMP:20260420T010736
CREATED:20250316T202422Z
LAST-MODIFIED:20250516T111006Z
UID:2356-1747746000-1747846800@esmit.eanm.org
SUMMARY:AD-LEARN mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders
DESCRIPTION:The course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles\, radiolabelling procedures\, and waste management. The program also covers novel PET radiotracers for molecular diagnosis of neurocognitive disorders. Additionally\, the course addresses patient and caregiver management and the role of Technologists in operating SPECT and PET equipment for AD and MCI imaging. Led by European experts\, the interactive sessions will allow participants to engage in discussions and ask questions\, fostering a deeper understanding of the subject.  \n\n\n\n\n\n\n\nRegister now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna\, here is your chance to follow the course live online! Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nTo gain knowledge about the methods and principles of radiolabelling and waste management with a special focus on radiation protection\n\n\n\nTo become educated in terms of radiotracers used in neurocognitive disorders diagnostic management\n\n\n\nTo learn the radiolabelling procedures’ adverse events basics and errors’ prevention\n\n\n\nTo be informed about the principles and importance of appropriate cooperation between medical professional\, patient and their caregiver before\, during and after SPECT and PET neurocognitive diseases’ imaging\n\n\n\nTo understand the roles and responsibilities of Technologists and Nurses in the nuclear medicine neurocognitive diseases’ diagnostic management\n\n\n\nTo improve the skills in terms of the interdisciplinary medical team collaboration focusing on Technologists/Nurses and other medical specialists’ cooperation.\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nTechnologists and Nurses\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nMarkus KӧhnerSpeakerErlangen\, Germany \n\n\n\n\n\nDaniela FonsecaSpeakerLondon\, UK \n\n\n\n\n\nValentina MautoneSpeakerMeldola\, Italy \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               Registration for this course is free\, but we will charge a €100 fee to book your seat\, which will be reimbursed upon attendance \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/ad-learn-mini-course-for-techs-and-nurses-the-value-and-challenges-of-brain-spect-in-pet-in-neurocognitive-disorders/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Instrumentation, Technology, Science,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250519T080000
DTEND;TZID=Europe/Vienna:20250520T120000
DTSTAMP:20260420T010736
CREATED:20250318T094512Z
LAST-MODIFIED:20250516T110910Z
UID:2372-1747641600-1747742400@esmit.eanm.org
SUMMARY:AD-LEARN Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders?
DESCRIPTION:The course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular\, cerebral SPET and PET will be addressed. \n\n\n\n\n\n\n\nRegister now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna\, here is your chance to follow the course live online! Register now\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nClinical introduction and positioning where imaging is indicated: The aim is to understand the main indications of cerebral SPET and PET methods and the patient’s preparation before the examination.\n\n\n\nPrimer course: how to read a brain SPECT study: the aim is to understand how to acquire\, reconstruct\, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.\n\n\n\nPrimer course: how to read an FDG-PET brain study: the aim is to understand how to acquire\, reconstruct\, format and read an FDG  brain PET/CT. The main clinical patterns will also be presented.\n\n\n\nPeer-learning with tips and tricks\, and case presentation: the aim is to understand how to acquire\, reconstruct\, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.\n\n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear medicine specialists with little or no experience in reading SPET and PET neurological imaging. \n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nIgor YakushevSpeakerMunich\, Germany \n\n\n\n\n\nStelvio SestiniSpeakerPrato\, Italy \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               Registration for this course is free\, but we will charge a €100 fee to book your seat\, which will be reimbursed upon attendance \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/esmit-ad-learn-mini-course-for-residents-how-to-start-reading-brain-scans-in-neurocognitive-disorders/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Instrumentation, Technology, Science,Onsite Course
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250515T090000
DTEND;TZID=Europe/Vienna:20250516T160000
DTSTAMP:20260420T010736
CREATED:20241017T083021Z
LAST-MODIFIED:20250311T115243Z
UID:1953-1747299600-1747411200@esmit.eanm.org
SUMMARY:CANCELLED: Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
DESCRIPTION:More information coming soon \n\n\n\nRegister nowThis course is cancelled. \n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\nMore information coming soon\n\n\n\n\n\n\n\nMore information coming soon\n\n\n\n\n\n\n\n\n\n\nProgrammeComing soon View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/focus-on-benign-thyroid-disease-from-thyroid-nodule-to-hyperthyroidism-and-immune-disease/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250509T133000
DTEND;TZID=Europe/Vienna:20250509T143000
DTSTAMP:20260420T010736
CREATED:20241017T080513Z
LAST-MODIFIED:20250505T100056Z
UID:1930-1746797400-1746801000@esmit.eanm.org
SUMMARY:Introducing Dosimetry in the Clinical Setting
DESCRIPTION:This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nThe aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup. \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nNuclear medicine clinicians and medical physicists \n\n\n\n \n\n\n\nSuggested Readings\n\n\n\n \n\n\n\n“EANM enabling guide: how to improve the accessibility of clinical dosimetry.” Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry \n\n\n\n\nClick Here\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nJonathan GearSpeaker \n\n\n\n\n\nPablo Mínguez GabiñaSpeaker \n\n\n\n\n\nEivor HernesSpeaker \n\n\n\n\n\nSilvano GnesinModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/introducing-dosimetry-in-the-clinical-setting/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250506T000000
DTEND;TZID=Europe/Vienna:20250507T235959
DTSTAMP:20260420T010736
CREATED:20250227T155357Z
LAST-MODIFIED:20250227T155357Z
UID:2278-1746489600-1746662399@esmit.eanm.org
SUMMARY:ESMO-EANM Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology
DESCRIPTION:Learning Objectives\n\n\n\n\nTo get an updated analysis of the diagnostic and therapeutic applications of nuclear medicine in oncology\n\n\n\nTo provide a knowledge of principles of both nuclear medicine modalities and systemic oncologic therapies in advanced trainees and specialists in oncology and nuclear medicine\n\n\n\nTo provide an educational framework for in-depth analysis of the combined diagnostic/therapeutic strategies (theranostics) in oncology and scientific interaction between oncology and nuclear medicine experts\n\n\n\nTo foster interdisciplinary exchange and collaboration in both nuclear medicine imaging and nuclear medicine treatment applications\n\n\n\n\n\nFind out moreMore information about the course\, including registration\, can be found on the ESMO website Find out more
URL:https://esmit.eanm.org/event/esmo-eanm-course-on-diagnostic-and-therapeutic-applications-of-nuclear-medicine-in-oncology/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250501T000000
DTEND;TZID=Europe/Vienna:20250501T235959
DTSTAMP:20260420T010736
CREATED:20240215T120025Z
LAST-MODIFIED:20250422T093546Z
UID:1344-1746057600-1746143999@esmit.eanm.org
SUMMARY:Gynaecological Malignancies
DESCRIPTION:UEMS EACCME has granted the accreditation of 3 CME credits for this event. \n\n\n\nThe present course aims to describe the current status\, in terms of diagnosis and therapy for gynecological cancers. All the gynecological malignancies (i.e.\, ovary cancer\, endometrial cancer\, cervical and vaginal cancer) will be evaluated from the oncological and from diagnostic point of view\, with a major emphasis on the role of nuclear medicine\, both in diagnosis and therapy.  \n\n\n\nThe speakers are specialists in oncology\, radiology and nuclear medicine with a clinical experience in gynecological cancer and will provide some examples that can be found in every day clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLearn about the current available therapies useful for the treatment of gynecological cancer; \n\n\n\nUnderstand the correct diagnostic flow-chart for the management of patients affected by gynecological cancer; \n\n\n\nDescribe the potential future perspectives in nuclear medicine to face gynecological cancer\, from a diagnostic and therapeutical point of view\n\n\n\n\n\n\n\nOncologists\, Radiologists\, Nuclear Medicine Physicians\, Technicians\, Endocrinologists\, Gynecologists\n\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the full event programme.  View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nCristina FerrariNuclear Medicine\, Italy \n\n\n\n\n\nGiulia TascaOncology\, Italy \n\n\n\n\n\nTeresa Margarida CunhaRadiology\, Portugal \n\n\n\n\n\n\n\nHelen Clare AddleyRadiology\, United Kingdom \n\n\n\n\n\nDesiree Deandreis Nuclear Medicine\, France \n\n\n\n\n\nOra Israel Nuclear Medicine\, Israel \n\n\n\n\n\n\n\nOzgul EckmekciogluNuclear Medicine\, Turkeye \n\n\n\n\n\nHenrique NabaisGynaecology\, Portugal \n\n\n\n\n\nMonica PiresGynaecology\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of Payment\n\nCourse Fee               € 300.- + Local VAT Rate \n\n\n\n\n\nCredit card via the ESMIT eLearning store \n\n\n\nCheques will not be accepted. \n\n\n\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired course under ‘Online Courses’  \n\n\n\nEnjoy!Once paid\, you get full access to the course contents on the ESMIT eLearning platform \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/gynaecological-malignancies/
LOCATION:Online
CATEGORIES:Clinical Nuclear Medicine,Self-paced Online Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250425T133000
DTEND;TZID=Europe/Vienna:20250425T143000
DTSTAMP:20260420T010736
CREATED:20241017T081307Z
LAST-MODIFIED:20250214T105155Z
UID:1936-1745587800-1745591400@esmit.eanm.org
SUMMARY:Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
DESCRIPTION:more information coming soon \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\nSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/highlights-of-focus-meeting-6-shaping-the-future-of-breast-cancer-care-with-molecular-imaging-prerecorded/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250410T090000
DTEND;TZID=Europe/Vienna:20250411T160000
DTSTAMP:20260420T010736
CREATED:20241017T083229Z
LAST-MODIFIED:20250318T094444Z
UID:1955-1744275600-1744387200@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:Internal radiotherapy with bone-seeking agents is effective in delivering high doses of radiation to widespread metastatic bone lesions and may limit the radiation absorbed dose to healthy tissue. Beta emitter have long been preferred agents for bone pain palliation. The approval of 223Ra and data showing a prolonged survival with alpha emitter are favored in bone pain palliation. Unfortunately\, we do not have good data on the survival after treatment with beta emitters. In the face-to-face course we will discuss the pathophysiology of bone pain to understand the principle of therapeutic effect of bone seeking agents. Dosimetry is essential to increase the dose to the tumor by limiting of severe side effects. All the focus is on the alpha emitters only\, based on the poor data about survival data for the beta emitters. The future of therapy in Nuclear Medicine is the combination with other agents to improve the therapeutic effect\, e.g. chemotherapy\, immunotherapy or anti-androgen therapy. \n\n\n\n\n\n\n\nRegister nowClick on the button to sign up for the course. Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nPathophysiology and medical treatment of bone pain\n\n\n\nPro/con alpha/beta emitters\n\n\n\nPerforming of dosimetry\n\n\n\nCombination treatment to improve the therapeutic effect\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear medicine physician\, junior or senior\, with an interest in treatment\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\nGiulia SantoSpeakerCatanzaro\, Italy \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250404T133000
DTEND;TZID=Europe/Vienna:20250404T143000
DTSTAMP:20260420T010736
CREATED:20241017T080415Z
LAST-MODIFIED:20250326T095143Z
UID:1928-1743773400-1743777000@esmit.eanm.org
SUMMARY:Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
DESCRIPTION:This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer\, highlighting recent clinical trials\, molecular targeting techniques\, and potential promising combination therapies. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nTo evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice\n\n\n\nTo learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions\n\n\n\nTo learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer\n\n\n\nTo improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Endocrinologist\, Oncologist \n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nPetra PetranovicSpeaker \n\n\n\n\n\nMichael KreisslSpeaker \n\n\n\n\n\nLuca GiovanellaModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radioiodine-refractory-thyroid-cancer-is-it-time-to-change-the-definition-in-the-light-of-novel-redifferentiation-therapies/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250328T133000
DTEND;TZID=Europe/Vienna:20250328T143000
DTSTAMP:20260420T010736
CREATED:20241017T080209Z
LAST-MODIFIED:20250312T095042Z
UID:1926-1743168600-1743172200@esmit.eanm.org
SUMMARY:Theranostic Training: Practical and Methodological Concepts
DESCRIPTION:This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes\, and how we can leverage these strengths in practice. \n\n\n\nPlease note that the webinar will be recorded\, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform\, under the webinar title. A handout of the presentation materials will also be available on the platform. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnroll in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nAttendees will understand the concept of theranostics and its significance in modern healthcare.\n\n\n\nAttendees will explore the foundational technologies behind theranostics and learn how departments can be organized to integrate theranostic procedures.\n\n\n\nAttendees will gain insights into the perspectives of physicians and technologists on theranostics and how these disciplines collaborate to deliver optimal patient outcomes.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nTechnologists\, Nurses\, Physicists\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nRiccardo LaudicellaSpeaker \n\n\n\n\n\nDaniela FonsecaSpeaker \n\n\n\n\n\nAngelo CardosoModerator \n\n\n\n\n\nConrad-Amadeus VoltinModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/theranostic-training-for-technologists/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250320T090000
DTEND;TZID=Europe/Vienna:20250321T160000
DTSTAMP:20260420T010736
CREATED:20241017T082921Z
LAST-MODIFIED:20250314T130204Z
UID:1951-1742461200-1742572800@esmit.eanm.org
SUMMARY:Cardiac Amyloidosis Imaging: History\, Status Quo and Outlook
DESCRIPTION:This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore\, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography\, cardiac MRI\, SPECT\, and PET\, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore\, the course participants should solve cases independently and discuss them with the other course participants. \n\n\n\n\n\n\n\nRegister nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course. \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nGain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.\n\n\n\nBecome familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.\n\n\n\nTo learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).\n\n\n\nTo independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.\n\n\n\nTo learn the possibilities of quantification of SPECT and PET.\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear physicians\, cardiologists\, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nStephan NekollaSpeakerMunich\, Germany \n\n\n\n\n\nRaffaella CalabrettaSpeakerVienna\, Austria \n\n\n\n\n\nCarmela NappiSpeakerNaples\,Italy \n\n\n\n\n\nDietrich BeitzkeSpeakerVienna\,Austria \n\n\n\n\nMichael PoledniczekSpeakerVienna\,Austria \n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/cardiac-amyloidosis-imaging-history-status-quo-and-outlook/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250307T133000
DTEND;TZID=Europe/Vienna:20250307T143000
DTSTAMP:20260420T010736
CREATED:20241017T080042Z
LAST-MODIFIED:20250224T082009Z
UID:1924-1741354200-1741357800@esmit.eanm.org
SUMMARY:Advantages of Long-Axial Field-of-View PET in Inflammation and Infection Imaging
DESCRIPTION:Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging. \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n\nAttendees will be able to describe the main advantages of LAFOV PET in patients with inflammatory and infectious disorders.\n\n\n\nAttendees will be able to understand how the increased sensitivity of LAFOV PET/CT allows for faster scanning and/or an important reduction in injected activity\, and how it also enables dynamic whole-body PET imaging\, studying molecular interactions between organ systems and even delayed imaging.\n\n\n\nAttendees will be able to see that ultrafast imaging can facilitate imaging of new patient groups such as critically ill patients\, patients admitted to intensive care with persistent infection or children without sedation.\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\, Residents\, Technologists\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n\n\nJoyce van SluisSpeaker \n\n\n\n\n\nLars GormsenSpeaker \n\n\n\n\n\nAndor GlaudemansSpeaker \n\n\n\n\n\nOliver GheysensModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/advantages-of-long-axial-field-of-view-pet-in-inflammation-and-infection-imaging/
CATEGORIES:Instrumentation, Technology, Science,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250221T133000
DTEND;TZID=Europe/Vienna:20250221T143000
DTSTAMP:20260420T010736
CREATED:20241017T075932Z
LAST-MODIFIED:20250217T121048Z
UID:1922-1740144600-1740148200@esmit.eanm.org
SUMMARY:Surgery in Neuroendocrine Neoplasms (NENs)
DESCRIPTION:Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells\, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases\, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs\, particularly in cases of primary tumours or oligometastatic disease\, where nuclear medicine imaging precisely localizes the lesions and surgical resection is feasible. \n\n\n\nThis session will explore the current landscape of radioguided surgery\, with a specific focus onneuroendocrine tumour applications. We will begin by reviewing the latest tracers and instrumentation employed in radioguided procedures\, discussing their mechanisms\, advantages\, and limitations. Following this\, we will delve into the clinical integration of these tracers and devices\, examining their role in the routine surgical workflow for NETs. By highlighting the practical implications and clinical outcomes\, this session aims to provide attendees with actionable insights into advancing care for patients with neuroendocrine tumours. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nAttendees will be able to describe the latest advancements in radiotracers and surgical instrumentation for radioguided neuroendocrine tumour surgery\, including their mechanisms of action and clinical benefits. \n\n\n\nAttendees will be able to evaluate the indications for radioguided surgery in neuroendocrine tumours\, such as primary tumours and oligometastatic disease\, based on pre-operative nuclear medicine imaging. \n\n\n\nAttendees will be able to outline the steps required to integrate novel radiotracers and devices into the clinical workflow\, from surgical planning to intraoperative application\, with a focus on improving patient outcomes.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nSurgical oncologists\, nuclear medical physicians\, medical physicists\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nThomas WendlerModerator \n\n\n\n\n\nPedro Fragoso Costa Speaker \n\n\n\n\n\nJohn Orozco CortesSpeaker \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/surgery-in-neuroendocrine-neoplasms-nens/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250213T090000
DTEND;TZID=Europe/Vienna:20250214T160000
DTSTAMP:20260420T010736
CREATED:20241017T082805Z
LAST-MODIFIED:20250214T120538Z
UID:1946-1739437200-1739548800@esmit.eanm.org
SUMMARY:Artificial Intelligence in Nuclear Medicine – Current Status and Future Perspective
DESCRIPTION:Artificial intelligence with the development of deep learning has found numerous applications in the medical field over the past few years\, including more specifically that of medical imaging. This includes most areas governing the medical imaging process from detector signal processing to image formation and subsequent image processing. The activity of deep learning spans from the more fundamental aspects such as image reconstruction and associated corrections to more clinical applications driven developments such as that of imaging biomarkers and their usage in patient classification for diagnosis or therapy response monitoring. Although most of these developments are still part of active research\, certain software solutions are slowly finding their way in mainstream clinical reality with multiple clinical evaluation studies currently underway. The course will cover an overview of the main developments of deep learning in the different areas of image formation\, processing and associated clinical applications within the field of nuclear medical imaging and associated multimodalities. Certain examples of potential clinical interest will be covered in each of the above-mentioned areas. \n\n\n\n\n\n\n\nRegister nowRegistration now closed. For last minute interest\, please contact esmit@eanm.org \n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nUnderstand the basic principles of deep learning algorithm development\n\n\n\nLearn the latest developments in the use of deep learning for image reconstruction in nuclear and multimodality imaging\n\n\n\nLearn the latest developments in the use of deep learning for image corrections (attenuation\, scatter\, etc) in nuclear and multimodality imaging\n\n\n\nLearn the latest developments in the use of deep learning for image processing (eg. segmentation\, biomarkers) in nuclear and multimodality imaging\n\n\n\nLearn the latest developments in the use of deep learning for potential clinical applications (low dose imaging\, dosimetry\, diagnosis\, predictive and prognostic modeling) in nuclear and multimodality imaging\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nMedical doctors (nuclear medicine\, radiology)\, Medical Physicists\, Technologists\n\n\n\n\n\n\n\n\n\nProgrammeView the preliminary programme. Please note it is subject to change. View the Programme\n\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nStephan NekollaSpeaker \n\n\n\n\n\nMartina SolliniSpeaker \n\n\n\n\n\nDimitris VisvikisSpeaker \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/artificial-intelligence-in-nuclear-medicine-current-status-and-future-perspective/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:AI & Quantification,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250207T133000
DTEND;TZID=Europe/Vienna:20250207T143000
DTSTAMP:20260420T010736
CREATED:20241017T075631Z
LAST-MODIFIED:20250203T100308Z
UID:1920-1738935000-1738938600@esmit.eanm.org
SUMMARY:Bone Scan Beyond Oncological Disease
DESCRIPTION:The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings\, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions\, pain assessment\, and soft-tissue evaluation. \n\n\n\nNew treatment options for cardiac amyloidosis are increasing interest in early diagnosis of the disease. DPD scan is an excellent and non-invasive diagnostic modality in this diagnosis\, but detailed local\, whole body and SPECT/CT including calculation of different ratios are necessary for an accurate diagnosis. The presentation showed the performance of the examination\, clinical and medical letter examples.  \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinSpeakerArlon\, Belgium \n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/bone-scan-beyond-oncological-disease/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241212T090000
DTEND;TZID=Europe/Vienna:20241213T120000
DTSTAMP:20260420T010736
CREATED:20240213T182114Z
LAST-MODIFIED:20250116T094547Z
UID:1247-1733994000-1734091200@esmit.eanm.org
SUMMARY:Algorithms for Dementia Imaging
DESCRIPTION:UEMS EACCME has granted the accreditation of 7 CME credits for this event. \n\n\n\nThe course will offer a comprehensive overview of basic\, theoretical and practical evidence-based concepts needed for a deep and thoughtful understanding of the use of [¹⁸F]FDG (FDG) Brain PET\, amyloid (Amy) PET and DaT SPECT in Neurological Disorders. A brief introduction will be given on the position that each imaging technique holds in the recent European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. Then\, short theoretical sessions on visual reading and semiquantification of FDG PET\, Amy PET and DaT SPECT will be associated with longer hands-on sessions\, for a practice-oriented learning specifically addressed to dementing disorders and neurodegenerative parkinsonian syndromes. Different approaches for semiquantification and subsequent scan reporting will be proposed and discussed. Clinical cases will be the starting point to better define the usefulness\, utility and accurate reading of PET and SPECT in Alzheimer’s disease\, other neurodegenerative dementias and Parkinsonian Syndrome.n coming soon \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last minute registration\, please email us at esmit@eanm.org Register now!\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo familiarise with the neuroimaging tools available to objectively assess brain glucose metabolism\, amyloid deposition and dopaminergic system integrity\, and their position in recent European recommendations \n\n\n\nTo learn strengths and weaknesses of different approaches for semiquantification \n\n\n\nTo appropriately choose a semi-quantitative support for image interpretation in various conditions\n\n\n\nThe course will provide important information on the most recent developments for an improved clinical practice\, of utmost importance for nuclear medicine physicians.\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nGeneral nuclear medicine specialists\, radiologists who want to update their knowledge on reading\, semiquantification and reporting of FDG PET\, Amy PET and DaT SPECT in terms of clinical indications\, reading skills and pitfalls. The constantly evolving role of Brain PET in neurodegenerative disorders makes the track of interest also for neurologists who want to improve their knowledge of cutting-edge Neuroimaging tools.\n\n\n\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nValentina BertiSpeakerFlorence\, Italy \n\n\n\n\n\nIgor YakushevSpeakerMunich\, Germany \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/algorhythms-for-dementia-imaging/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241206T133000
DTEND;TZID=Europe/Vienna:20241206T143000
DTSTAMP:20260420T010736
CREATED:20240213T193126Z
LAST-MODIFIED:20241203T102334Z
UID:1300-1733491800-1733495400@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:With the arrival of new therapeutic tracers\, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy\, medical treatment\, chemotherapy). \n\n\n\nLearning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities and limitations of alpha and beta therapy in metastatic bone pain treatment \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nJules Zhang-YinModeratorArlon\, Belgium \n\n\n\n\n\n\n\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents-msk/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241202T100000
DTEND;TZID=Europe/Vienna:20241202T110000
DTSTAMP:20260420T010736
CREATED:20240702T080051Z
LAST-MODIFIED:20241119T122958Z
UID:1737-1733133600-1733137200@esmit.eanm.org
SUMMARY:Japanese vs. European View on Amyloid Imaging and Therapy (in collaboration with JSNM)
DESCRIPTION:The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However\, due to differences in clinical processes and insurance systems in each country\, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe\, CSF diagnosis is often performed first and amyloid PET is performed in selected patients. In Japan\, only either CSF diagnosis or amyloid PET is covered by public insurance\, so there is a trend toward performing the more expensive PET first. The use of amyloid PET in the setting of anti-AB therapy monitoring\, and its exact positioning in the biomarkers  flow-chart is not yet clearly defined. This webinar will present recent findings on the usefulness of amyloid PET and the differences in actual use between Europe and Japan. \n\n\n\nLearning Objectives: tba \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDonatienne Van WeehaegheModerator \n\n\n\n\n\n\n\n\n\n\n\nProf. Dr. med. Dr. biol. hum. Matthias Brendel\, MHBASpeakerDepartment leadBoard certified Nuclear Medicine physician Research lead for neurodegenerative disorders LMU Klinikum   Department of Nuclear MedicineUniversity Hospital of Munich \n\n\n\n\n\nDr. Kenji IshiiSpeakerDirectorDiagnostic Neuroimaging ResearchTokyo Metropolitan Institute for Geriatrics and GerontologyTokyo\, Japan \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/japanese-vs-european-view-on-amyloid-imaging-and-therapy-in-collaboration-with-jsnm/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241122T133000
DTEND;TZID=Europe/Vienna:20241122T143000
DTSTAMP:20260420T010736
CREATED:20240213T192901Z
LAST-MODIFIED:20241004T123239Z
UID:1298-1732282200-1732285800@esmit.eanm.org
SUMMARY:Challenges of Zr89 Imaging
DESCRIPTION:While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging\, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies\, the radionuclide is non-ideal imaging qualities mostly due to its low dosage\, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging\, the clinically relevant opportunities for the radionuclide\, and the quantification challenges\, handling and the safety aspects of Zr-89. \n\n\n\nLearning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFloris H.P. van VeldenModeratorLeiden\, Netherlands \n\n\n\n\n\nErik AarntzenSpeakerNijmegen\, Netherlands \n\n\n\n\n\nMarc C. HuismanSpeakerAmsterdam\, Netherlands \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/challenges-of-zr89-imaging/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241114T080000
DTEND;TZID=Europe/Vienna:20241115T170000
DTSTAMP:20260420T010736
CREATED:20240213T181944Z
LAST-MODIFIED:20241031T131739Z
UID:1243-1731571200-1731690000@esmit.eanm.org
SUMMARY:Focus on Molecular-guided Surgery
DESCRIPTION:An application has been submitted to the UEMS EACCME for CME accreditation. \n\n\n\nThe course has a hybrid format with on-site lectures and hands-on practical and technic sessions\, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist’s work and support the multidisciplinary team in charge of Radioguided procedures.   \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org \n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nThis course aims to spread information and practice to technologist\, nurses\, medical staff (nuclear medicine\, surgeons\, radiologist)  in order to provide an interactive setting to share ideas and refine current and future approaches in the field of Radioguided Surgery\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nTo Define the radioguided surgery principles\, applications\, methodology. \n\n\n\nOverview the current state of the art of the radioguided surgery. \n\n\n\nList the clinical indications of introducing radioguided surgery to the patients. \n\n\n\nExplain the paper of a multidisciplinary team in the context of radioguided surgery. \n\n\n\nProtocols and methodologies of conventional NM exams used in radioguided surgery \n\n\n\nConventional nuclear medicine in the context of radioguided surgery: best practice\, radiation protection and safety\, organisation and patient management. \n\n\n\nTo provide the potential benefits of new technologies like IA and future perspectives.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nSergi Vidal-SicartSpeaker \n\n\n\n\n\nChiara Maria GranaSpeaker \n\n\n\n\n\nRenato Valdés OlmosSpeaker \n\n\n\n\n\nJohn OrozcoSpeaker \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 863.64 \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/focus-on-molecular-guided-surgery/
LOCATION:Hospital Clínico de Barcelona\, Carrer de Villarroel\, 170\, L'Eixample\, Barcelona\, 08036\, Spain
CATEGORIES:Clinical Nuclear Medicine,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241108T133000
DTEND;TZID=Europe/Vienna:20241108T143000
DTSTAMP:20260420T010736
CREATED:20240213T192553Z
LAST-MODIFIED:20240723T085928Z
UID:1296-1731072600-1731076200@esmit.eanm.org
SUMMARY:Artificial Intelligence in Dosimetry
DESCRIPTION:The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within the dosimetry workflow for targeted radionuclide therapy. First\, AI methods for reducing SPECT acquisition times\, noise reduction and scatter correction will be covered. Thereafter\, AI methods for organ segmentation and voxel-based dosimetry\, together with AI methods for pre-therapeutically dosimetry estimate will be highlighted. \n\n\n\nLearning Objectives: The aim of this webinar is to understand the basics of AI methodologies used for dosimetry and receive knowledge about the current status of AI applications within dosimetry for targeted radionuclide therapies. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nPeter BernhardtModeratorGöteborg\, Sweden \n\n\n\n\n\n\n\n\n\n\n\nYuni Dewaraja  SpeakerMichigan\, USA \n\n\n\n\n\nJohannes Tran-GiaSpeakerWürzburg\, Germany \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/artificial-intelligence-in-dosimetry/
CATEGORIES:AI & Quantification,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240926T090000
DTEND;TZID=Europe/Vienna:20240927T170000
DTSTAMP:20260420T010736
CREATED:20240213T181746Z
LAST-MODIFIED:20240916T051241Z
UID:1240-1727341200-1727456400@esmit.eanm.org
SUMMARY:Quantification of MPI
DESCRIPTION:UEMS EACCME has granted the accreditation of 10\,5 CME credits for this event. \n\n\n\nThis course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects\, details of radiotracers utilised\, examination protocols and case examples of myocardial perfusion imaging (MPI) using PET and SPECT will be discussed at the event. The focus here will be on the quantification of data (e.g. abnormality scores\, myocardial blood flow\, myocardial flow reserve) collected from MPI. The event will allow for both lectures and discussions and will be an interactive event. Pitfalls and regulatory aspects will be covered as well in this course. \n\n\n\n\n\n\n\nSave yourself a seatRegistration closed. For last-minute sign up please contact esmit@eanm.org Closed\n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\n\nThe target audience includes nuclear medicine physicians\, cardiologists\, internists and radiologists who want to deepen their knowledge in the field of imaging coronary artery disease.\n\n\n\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\n\nGain a deep insight into nuclear medicine imaging of coronary artery disease.\n\n\n\nBecome familiar with radiopharmaceuticals\, camera systems\, examination protocols and regulatory aspects.\n\n\n\nTo learn SPECT\, PET image interpretation based on visual analysis and quantification.\n\n\n\nThe technique of absolute quantification of myocardial blood flow using PET or CZT cameras.\n\n\n\nAdditional value of hybrid imaging (SPECT/CT\, PET/CT and PET/MRI) in CAD.\n\n\n\nDiscussion of cases\, pearls and pitfalls.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\n\nStephan  NekollaSpeakerTechnical University Munich\, Germany \n\n\n\n\n\nCarmela  NappiSpeakerUniversity of Naples Federico II\, Italy \n\n\n\n\n\nFederico  CaobelliSpeakerUniversitätsspital Bern\, Switzerland \n\n\n\n\n\nRaffaella  CalabrettaSpeakerMedizinische Universität Wien\, Austria \n\n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee Breaks on each Course Day\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/quantification-of-mpi/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:AI & Quantification,Onsite Course
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240920T133000
DTEND;TZID=Europe/Vienna:20240920T143000
DTSTAMP:20260420T010736
CREATED:20240213T192107Z
LAST-MODIFIED:20240731T083213Z
UID:1294-1726839000-1726842600@esmit.eanm.org
SUMMARY:Paediatric Nuclear Medicine in Nephro-Urology
DESCRIPTION:The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology\, with particular attention to the choice of the radiotracer\, the correct patient preparation\, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and hydroureteronephrosis\, spacing from typical pelvicureteral junction obstruction to obstructive megaureter\, and some complex malformations\, such as duplex kidneys. The selected cases will pinpoint the critical clues used in interpreting and reporting the scintigraphic studies and the integration of scintigraphic data with other imaging modalities (ultrasounds\, MRI\, etc.) in evaluating paediatric nephrourology patients. \n\n\n\nLearning Objectives: The aim of this course is to review the methodology and the main indications for scintigraphic studies in paediatric nephro-urology\, taking into accounts the more relevant and recent international guidelines and offering various examples taken from the current clinical practice. \n\n\n\nSuggested Readings:1. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children2. EANM procedural recommendations for managing the paediatric patient diagnostic nuclear medicine \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDiego CecchinModeratorPadua\, Italy \n\n\n\n\n\nPietro ZucchettaSpeakerPadua\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/paediatric-nuclear-medicine-in-nephro-urology/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240906T133000
DTEND;TZID=Europe/Vienna:20240906T143000
DTSTAMP:20260420T010736
CREATED:20240213T191555Z
LAST-MODIFIED:20240710T090914Z
UID:1291-1725629400-1725633000@esmit.eanm.org
SUMMARY:FDG-PET/CT in Breast Cancer
DESCRIPTION:Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality\, therefore being a major concern. 2-[18F]FDG PET/CT is commonly used in the clinical management of patients with breast cancer\, with significant impact on clinical management. Currently\, there is robust evidence supporting the usefulness of 2-[18F]FDG PET/CT in the initial staging of patients with locally advanced and metastatic breast cancer\, in the early assessment of treatment response and in the early detection of recurrence. The first presentation of this webinar will summarize the recently published “Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer” which was endorsed by other relevant societies in the subject of breast cancer (ACR\, ESSO\, ESTRO\, EUSOBI/ESR\, and EUSOMA). Updated information to support the recommendations to perform 2-[18F]FDG PET/CT in no special type breast cancer in different clinical settings will be provided. Despite no special type breast cancer presenting high 2-[18F]FDG avidity\, other breast cancer subtypes seem to be better evaluated with other PET radiopharmaceuticals. Therefore\, the second presentation will address the potential role of [18F]FES\, [89Zr]Trastuzumab\, [18F]Sodium fluoride (NaF)\, [18F]Fluciclovine (FACBC)\, [89Zr]Pembrolizumab and FAPI-ligands in breast cancer. During this webinar we want to brainstorm about the role of PET/CT in the different subtypes and clinical scenarios of patients with breast cancer. The webinar will be enriched by interactive clinical case discussion\, aiming to resemble the challenges found in daily clinical practice. \n\n\n\nLearning Objectives:  \n\n\n\n\nGeneral aspects to avoid false positive and false negative findings on 2-[18F]FDG PET/CT.\n\n\n\nDiagnostic accuracy of 2-[18F]FDG PET/CT compared to conventional imaging modalities.\n\n\n\nRecommendations for performing 2-[18F]FDG PET/CT in the initial staging\, in assessing response to therapy and in assessing recurrence.\n\n\n\nAppropriate PET radiopharmaceuticals to better address each breast cancer subtype.\n\n\n\nSpecific characteristics\, physiological biodistribution\, advantages and disadvantages of PET radiopharmaceuticals used in breast cancer beyond 2-[18F]FDG.\n\n\n\nGeneral interpretation criteria to optimize the information provided in the final PET/CT report.\n\n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nLioe-Fee de Geus-OeiModeratorLeiden\, Netherlands \n\n\n\n\n\nSofia VazSpeakerLisbon\, Portugal \n\n\n\n\n\nLidija AntunovicSpeakerMilan\, Italy \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-breast-cancer/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240705T133000
DTEND;TZID=Europe/Vienna:20240705T143000
DTSTAMP:20260420T010736
CREATED:20240213T191043Z
LAST-MODIFIED:20240701T122643Z
UID:1289-1720186200-1720189800@esmit.eanm.org
SUMMARY:Guidelines for the Use of FDG PET/CT in Infection and Inflammation 2.0
DESCRIPTION:General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. \n\n\n\nLearning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation\, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nAndor GlaudemansModeratorGroningen\, Netherlands \n\n\n\n\n\n\n\n\n\n\n\nOlivier GheysensSpeakerBrussels\, Belgium \n\n\n\n\n\nGad AbikhzerSpeakerMontreal\, Canada \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/guidelines-for-the-use-of-fdg-pet-ct-in-infection-and-inflammation-2-0/
CATEGORIES:Clinical Nuclear Medicine,Live Webinars
END:VEVENT
END:VCALENDAR